Carotid Stenosis and TAVR

Aortic Stenosis affects over 5% of the population over 65. 

Estenosis carotídea y TAVI

Even though TAVR has advanced in the treatment of this disease, many patients present carotid aortic stenosis (CAS), which involves additional surgical risk. This risk has not been thoroughly assessed in the context of TAVR. 

A meta-analysis was carried out including 5 observational studies with a total 111,915 patients. Mean patient age was 83 and 46% were women.

Stroke or transient ischemic attack (TIA) rate was higher in patients presenting CAS (OR 1.44; CI 95% 1.07–1.95; p = 0.016), with no significant differences in myocardial infarction (OR 1.24; CI 95% 1.05–1.47; p = 0.074), all-cause mortality (OR 0.99; CI 95% 0.71–1.37; p = 0.94), acute kidney failure (OR 0.98; CI 95% 0.90–1.06) and the need for pacemaker implantation after TAVR (OR 0.95; CI 95% 0.70–1.30; p = 0.759) between both groups.

Conclusión

This analysis revealed a link between carotid stenosis and cerebrovascular events in patients undergoing TAVR, with no significant impact on all-cause mortality. We highlight the need for prospective studies for a more detailed assessment of additional determinants of this association, such as unilateral or bilateral compromise and stenosis degree, which increases risk. 

Original Title: Impact of carotid artery stenosis on outcomes of transcatheter aortic valve replacement: A systematic review and meta-analysis.

Reference: Lucas Caetano da Silva, et al. International Journal of Cardiology, https://doi.org/10.1016/j.ijcard.2023.131670.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...